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Abstract
Sphingosine 1-phosphate (S1P) receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on
Lysophospholipid receptors [70]) are activated by the endogenous lipid sphingosine 1-phosphate (S1P).
Originally cloned as orphan members of the endothelial differentiation gene (edg) family, current gene names
have been designated as S1P1R through S1P5R [52]. S1PRs, particularly S1P1, are expressed throughout all
mammalian organ systems. Ligand delivery occurs via two known carriers (or "chaperones"): albumin and HDL-
bound apolipoprotein M (ApoM), the latter of which elicits biased agonist signaling by S1P1 in multiple cell types
[15, 39]. The five S1PRs, two chaperones, and active cellular metabolism have complicated analyses of receptor
ligand binding in native systems. Signaling pathways and physiological roles have been characterized through
radioligand binding in heterologous expression systems, targeted deletion of the different S1PRs, and most
recently, mouse models that report in vivo S1P1R activation [74, 76]. A crystal structure of an S1P1-T4 fusion
protein confirmed aspects of ligand binding, specificity, and receptor activation determined previously through
biochemical and genetic studies [48, 14]. fingolimod (FTY720), the first drug to target any of the lysophospholipid
receptors, binds to four of the five S1PRs, and was the first oral therapy for multiple sclerosis [26]. The
mechanisms of action of fingolimod and other S1PR modulating drugs in development include binding S1PRs in
multiple organ systems, e.g., immune and nervous systems, although the precise nature of their receptor
interactions requires clarification [107, 28, 43, 44].
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